Combination nucleos(t)ide analogue as initial treatment for chronic hepatitis B: Have we put this to rest?


  • Anna Suk-Fong Lok M.D.

    Corresponding author
    1. University of Michigan, Ann Arbor, MI
    • Address reprint requests to: Anna S.F. Lok, M.D., Division of Gastroenterology and Hepatology, University of Michigan Health System, 1500 East Medical Center Dr., 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109. E-mail: fax: 734-936-7392

    Search for more papers by this author

  • See Article on Page 505

  • Potential conflict of interest: Research grants: Bristol-Myers Squibb, Gilead, Merck. Advisory panel: Gilead, GlaxoSmithKline, Novartis, Merck, Roche.

No abstract is available for this article.